Natural and artificial bleomycins: chemistry and antitumor activities.

Natural and artificial bleomycins: chemistry and antitumor activities. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Natural and artificial bleomycins: chemistry and antitumor activities. Abstract Text:

Natural and artificial bleomycins: chemistry and antitumor activities. Publishing Authors By Initials

For similar neoplasms: neoplasms, experimental research abstracts see: neoplasms: neoplasms, experimental research

PUBMED ID PMID:

MEDLINE DATE:

Natural and artificial bleomycins: chemistry and antitumor activities. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Pure and applied chemistry. Chimie pure et appliqu

VOLUME: 28

Page Numbers: 665-80

Journal Abbreviation: Pure Appl. Chem.

ISSN: 0033-4545

DAY: 26

MONTH: 02

YEAR: 1971

Natural and artificial bleomycins: chemistry and antitumor activities. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 376514

Natural and artificial bleomycins: chemistry and antitumor activities. Keywords Mesh Terms:

KEYWORDS: Neoplasms, Experimental

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Natural and artificial bleomycins: chemistry and antitumor activities. Information

Substance Name: Bleomycin

Registry Number: 11056-06-7

Grant and Affiliation Information for Natural and artificial bleomycins: chemistry and antitumor activities.

AFFILIATION:

Country: ENGLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Pure Appl Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Natural and artificial bleomycins: chemistry and antitumor activities Related Publications

• A genetic method to identify mitochondrial proteins in living Mammalian cells.
• Bleomycin and other antitumor antibiotics of high molecular weight.
• Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
• Fundamental studies on bestatin: a small molecular microbial product enhancing immune response.
• Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts.
• Identification of proteins targeted into the endoplasmic reticulum by cDNA library screening.
• Inhibition of CDP-DG: inositol transferase by inostamycin.
• Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor.
• Inhibition of nucleic acid biosynthesis in cell-free systems of Escherichia coli B by pluramycin.
• Inhibition of protein synthesis by bottromycin A2 and its hydrazide.
• Kinetic studies on the inhibition of nucleoside diphosphate kinase by desdanine.
• Local-density approximation for orbital densities applied to the self-interaction correction.
• Mechanism of kasugamycin action on polypeptide synthesis.
• Messenger RNA-associated 30S ribosomal subunit: extraction from E. coli and the effect of chloramphenicol on the content.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. 3. On the weak inhibition of polyphenylalanine synthesis directed by polyuridylic acid.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. I. Inhibition of protein synthesis.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. II. Preferential binding of enomycin to mammalian ribosomes.
• NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
• Natural and artificial bleomycins: chemistry and antitumor activities.
• New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
• New microbial secondary metabolites under preclinical development for cancer treatment.
• Optical probes to identify the glucocorticoid receptor ligands in living cells.
• Pyruvate kinase of Escherichia coli. Its role in supplying nucleoside triphosphates in cells under anaerobic conditions.
• Screening of small molecular microbial products modulating immune responses and bestatin.
• Studies on antitumor substances of microbial origin.
• The subunit composition of hinokiresinol synthase controls geometrical selectivity in norlignan formation.
• Ways for a mesenchymal stem cell to live on its own: maintaining an undifferentiated state ex vivo.
• [Method for determination of the bleomycin inactivating enzyme acitivity in tissues]
• [Screening of bioactive metabolites that suppress inflammation]
• [Uptake and translocation of 14C-labelled Kasugamycin in rice plants]